To determine which molecules were involved in signaling downstream of the ERK MAPK pathway to modulate Sp1 gene expression, the phosphorylation of MSK, which can be activated by MAPK/ERK and p38, was analyzed in six paired CD34+ and CD34- AML patients. The gene discussed is MAPK14; the disease is acute myeloid leukemia.